Jw Pharmaceutical Corporation logo

Jw Pharmaceutical Corporation (001060)

Market Closed
12 Dec, 06:30
KRX SM KRX SM
27,250. 00
-150
-0.55%
565.99B Market Cap
- P/E Ratio
1,800% Div Yield
73,364 Volume
- Eps
27,400
Previous Close
Day Range
27,050 27,850
Year Range
19,600 28,150
Want to track 001060 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 53 days

Summary

001060 closed Friday lower at ₩27,250, a decrease of 0.55% from Thursday's close, completing a monthly increase of 2.83% or ₩750. Over the past 12 months, 001060 stock gained 13.07%.
001060 is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 225.08%, based on the last three reports. The next scheduled earnings report is due on Feb 05, 2026.
Jw Pharmaceutical Corporation has completed 5 stock splits, with the recent split occurring on Dec 27, 2023.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

001060 Chart

Similar

Cheil Bio Co., Ltd.
3,120,059.25
0%
Hyundai Motor Co.
302,000
+2.2%
Hyundai Motor Co. Ltd.
204,000
+2.05%
Hyundai Motor Co. Ltd. Preferred
207,000
+2.22%
Hyundai Motor Co., Ltd. Preferred
209,500
+2.44%

Jw Pharmaceutical Corporation (001060) FAQ

What is the stock price today?

The current price is ₩27,250.00.

On which exchange is it traded?

Jw Pharmaceutical Corporation is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 001060.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1,800%.

What is its market cap?

As of today, the market cap is 565.99B.

When is the next earnings date?

The next earnings report will release on Feb 05, 2026.

Has Jw Pharmaceutical Corporation ever had a stock split?

Jw Pharmaceutical Corporation had 5 splits and the recent split was on Dec 27, 2023.

Jw Pharmaceutical Corporation Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Young-Sub Shin CEO
KRX SM Exchange
KR7001060003 ISIN
KR Country
1,048 Employees
- Last Dividend
27 Dec 2023 Last Split
- IPO Date

Overview

JW Pharmaceutical Corporation operates both within Japan and internationally, engaging in the manufacturing and distribution of medicines and medical supplies. Since its inception in 1945, the company has grown to become a vital player in the healthcare industry, providing a wide range of products aimed at improving the health and well-being of its customers. Based in Gwacheon-si, South Korea, JW Pharmaceutical Corporation has dedicated itself to addressing various medical needs, spanning from critical areas such as cancer and immunological diseases to general health and beauty care.

Products and Services

  • Cancer, Immunological Disease, Cardiovascular System and Metabolic Diseases, Regenerative Medicine, Eye Diseases, and Pancreatic Cancer Products

    The core of JW Pharmaceutical Corporation's product line focuses on the development and distribution of treatments for major health concerns, including cancer, immunological diseases, cardiovascular and metabolic diseases, regenerative medicine, eye diseases, and specifically pancreatic cancer. Through intensive research and development, the company strives to bring innovative medicines to the market, hoping to improve patient outcomes in these critical areas.

  • Infant Care System, Gynecological Examining Table, Operating Room Equipment, Steam Sterilizer

    Beyond pharmaceuticals, JW Pharmaceutical Corporation offers a range of medical equipment designed to support healthcare professionals. This includes infant care systems for the youngest patients, gynecological examining tables for women's health, a variety of operating room equipment for surgical needs, and steam sterilizers for ensuring the sterility of medical tools and environments.

  • Wound Care, Pain Care, and Beauty Care Related Products

    Addressing the everyday health and wellness needs of individuals, JW Pharmaceutical Corporation has also developed products focusing on wound care, pain management, and beauty care. These products aim to enhance the quality of life for their users by providing relief and support for common health and aesthetic concerns.

Contact Information

Address: JW Gwacheon Tower, 38, Gwacheon-si, South Korea, 13840
Phone: 82 2 8406 777